Michael Powell
Chairman at GALERA THERAPEUTICS, INC.
Net worth: - $ as of 2024-04-29
Network origin in Michael Powell first degree
Entity | Entity type | Industry | |
---|---|---|---|
University of Toronto
324
| College/University | Other Consumer Services | 324 |
American Association of Pharmaceutical Scientists
American Association of Pharmaceutical Scientists BiotechnologyHealth Technology The American Association of Pharmaceutical Scientists engages in research and development of pharmaceutical products. The private company is based in Arlington, VA. The company was founded by Leslie Z. Benet.
84
| Private Company | Biotechnology | 84 |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA.
78
| Subsidiary | Biotechnology | 78 |
Sofinnova Investments, Inc.
Sofinnova Investments, Inc. Investment ManagersFinance Sofinnova Investment Inc (Sofinnova Investment) is a venture capital firm founded in 1976 by Jacques F. vallle & Joel F. Martin. The firm is headquartered in Menlo Park, California.
53
| Private Company | Investment Managers | 53 |
Subsidiary | Pharmaceuticals: Major | 32 | |
Subsidiary | Biotechnology | 25 | |
Subsidiary | Pharmaceuticals: Major | 25 | |
Threshold Pharmaceuticals, Inc.
Threshold Pharmaceuticals, Inc. BiotechnologyHealth Technology Threshold Pharmaceuticals, Inc. engages in the development of therapeutics for treating tumors. It offers the Evofosfamide which designed as a prodrug that is activated under the extreme hypoxic conditions commonly found in tumors, but not typically in healthy tissues, and TH-3424 which is a small-molecule drug candidate for the treatment of liver, castrate resistant prostate cancer, T-cell acute lymphoblastic leukemias, and other cancers. The company was founded by Jeffrey W. Bird on October 17, 2001 and is headquartered in South San Francisco, CA
22
| Extinct | Biotechnology | 22 |
Omega Fund Management LLC
Omega Fund Management LLC Investment ManagersFinance Omega Fund Management Ltd. (OFM) is the wholly-owned private equity firm founded by Dr. Otello Stampacchia in 2004. The firm is headquartered in the US.
22
| Private Company | Investment Managers | 22 |
Public Company | Biotechnology | 21 | |
Public Company | Pharmaceuticals: Major | 18 | |
Trius Therapeutics, Inc.
Trius Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Trius Therapeutics, Inc. is a biopharmaceutical company which focuses on the discovery, development and commercialization of innovative antibiotics for life-threatening infections. It engages in developing tedizolid phosphate an intravenous, or IV, and oral antibiotic, for the treatment of serious gram-positive bacterial infections, initially for acute bacterial skin and skin structure infections, ABSSSI, and subsequently for other indications, including pneumonia. ABSSSI is a new classification for complicated skin and skin structure infections, or cSSSI. Tedizolid phosphate is an IV and orally administered second generation oxazolidinone. The company develops antibiotics for gram-negative infections. Trius Therapeutics was founded by John Finn and John P. Schmid in June 2004, and is headquartered in San Diego, CA.
18
| Extinct | Pharmaceuticals: Major | 18 |
Mirna Therapeutics, Inc.
Mirna Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Mirna Therapeutics, Inc. is a biopharmaceutical company, which engages in the development of microRNA-based oncology therapeutics. Its products includes miR-34, miR-215, miR-101, miR-16, and let-7. The company was founded Matthew M. Winkler in 2007 and is headquartered in Austin, TX.
16
| Extinct | Miscellaneous Commercial Services | 16 |
AlgoRx Pharmaceuticals, Inc.
AlgoRx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology AlgoRx Pharmaceuticals, Inc. was a pharmaceutical company. The company developed and commercialized drugs for pain management. The company was founded in 2001 and was hedquartered in Secaucus, NJ.
10
| Extinct | Pharmaceuticals: Major | 10 |
Synlogic Operating Co., Inc.
Synlogic Operating Co., Inc. Pharmaceuticals: MajorHealth Technology Synlogic Operating Co., Inc. operates as a biopharmaceutical company. The firm's pipeline focuses on rare diseases, the company is leveraging the broad potential of its synthetic biotics platform for novel drug development in major disease areas through partnerships with pharmaceutical and biotechnology companies. It also engages in development of synthetic biotics-based treatment for inflammatory bowel disease. The company was founded by James J. Collins and Timothy K. Lu in 2014 and is headquartered in Cambridge, MA.
9
| Subsidiary | Pharmaceuticals: Major | 9 |
Aerium Therapeutics, Inc.
Aerium Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Aerium Therapeutics, Inc. is an American biotechnology company that focuses on epidemic and pandemic preparedness. The company is based in Lausanne and has operations in the United States. The company's mission is to discover and develop antibodies and small molecule antivirals against SARS-CoV-2 and other epidemic and pandemic threats. Aerium Therapeutics has a team of world-class scientists and biotechnology veterans, as well as experienced investors. Aerium's lead assets are monoclonal antibodies that show broad activity against important variants of concern (VOCs) of SARS-CoV-2, including Omicron and its subvariants. The company plans to expand its pipeline to antiviral therapeutics in late 2022 and will broaden its focus to other epidemic and pandemic threats in the future. The CEO of the company is Rajeev Venkayya.
8
| Holding Company | Miscellaneous Commercial Services | 8 |
Intrepida Bio, Inc.
Intrepida Bio, Inc. Pharmaceuticals: MajorHealth Technology Intrepida Bio, Inc. discovers and develops medicines to modulate the innate immune system to fight cancer and other diseases. The company was founded by Joel F. Martin and Olivier Laurent and is headquartered in San Diego, CA.
8
| Private Company | Pharmaceuticals: Major | 8 |
Dauntless Pharmaceuticals, Inc.
Dauntless Pharmaceuticals, Inc. Drugstore ChainsRetail Trade Dauntless Pharmaceuticals, Inc. develops specialty therapeutics via a one-asset, one-company model that is structured to facilitate operational efficiencies. The company was founded by Joel F. Martin and Michael F. Powell in May 2015 and is headquartered in San Diego, CA.
5
| Holding Company | Drugstore Chains | 5 |
Extinct | Precious Metals | 4 | |
Aeovian Pharmaceuticals, Inc.
Aeovian Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Aeovian Pharmaceuticals, Inc. engages in the development of pharmaceuticals. It offers inhibitors for the treatment of rare and age-related diseases. The company was founded by Stelios T. Tzannis in 2012 and is headquartered in Novato, CA.
4
| Holding Company | Pharmaceuticals: Major | 4 |
Dauntless 1, Inc.
Dauntless 1, Inc. Pharmaceuticals: MajorHealth Technology Dauntless 1, Inc. engages in pharmaceuticals. The company is headquartered in San Diego, CA.
2
| Private Company | Pharmaceuticals: Major | 2 |
Cytel Corp.
2
| Extinct | 2 | |
Dauntless 2, Inc.
Dauntless 2, Inc. Pharmaceuticals: MajorHealth Technology Dauntless 2, Inc. operates in the healthcare industry focused on pharmaceutical business. The company is headquartered in San Diego, CA.
2
| Private Company | Pharmaceuticals: Major | 2 |
Syntex Research Centre
Syntex Research Centre Pharmaceuticals: OtherHealth Technology Syntex Research Centre is a British company that provides pharmaceutical products. Syntex Research Centre was acquired by Quintiles Scotland Ltd on February 01, 1995 for $20.68 million.
1
| Extinct | Pharmaceuticals: Other | 1 |
AIDS Vaccine Advocacy Coalition
1
| Non-Profit Organization | 1 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Michael Powell via their personal network
Company | Sector | Related people | Main position |
---|---|---|---|
PFIZER, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Chief Tech/Sci/R&D Officer Corporate Officer/Principal General Counsel Human Resources Officer | |
Biotechnology Innovation Organization
Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Chief Executive Officer Chairman Director/Board Member Director/Board Member Director/Board Member Director/Board Member | |
Princeton University | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
The University of Chicago | College/University | Masters Business Admin Doctorate Degree Doctorate Degree Doctorate Degree Corporate Officer/Principal | |
Massachusetts Institute of Technology | College/University | Doctorate Degree Corporate Officer/Principal Corporate Officer/Principal Graduate Degree Doctorate Degree | |
ABBOTT LABORATORIES | Medical Specialties | President Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
University of California San Diego | College/University | Corporate Officer/Principal Doctorate Degree Doctorate Degree Corporate Officer/Principal Undergraduate Degree | |
Harvard Business School | College/University | Masters Business Admin Masters Business Admin Corporate Officer/Principal Masters Business Admin Masters Business Admin | |
Stanford University | College/University | Undergraduate Degree Masters Business Admin Doctorate Degree Undergraduate Degree Undergraduate Degree | |
Yale University | College/University | Doctorate Degree Doctorate Degree Graduate Degree Doctorate Degree | |
Boston University | College/University | Masters Business Admin Corporate Officer/Principal Masters Business Admin Undergraduate Degree | |
AMGEN INC. | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal Corporate Officer/Principal General Counsel | |
Millennium Pharmaceuticals, Inc.
Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Director of Finance/CFO | |
Harvard University
Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Doctorate Degree Undergraduate Degree Corporate Officer/Principal | |
Purdue University | College/University | Masters Business Admin Graduate Degree Corporate Officer/Principal | |
Amplyx Pharmaceuticals, Inc.
Amplyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Amplyx Pharmaceuticals, Inc. develops broad-spectrum antifungal agents for the treatment of life-threatening fungal infections. The firm's compound APX001, shows broad-spectrum activity in animal models of invasive fungal infection by common species of Candida and Aspergillus. It develops oral and injectable anti-infective drugs, including protease inhibitors and antibiotics. The company was founded by André Marquis, Mitchell W. Mutz and Gerry Crabtree in 2006 and is headquartered in San Diego, CA. | Pharmaceuticals: Major | Director of Finance/CFO Director/Board Member Director/Board Member | |
BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Sales & Marketing Corporate Officer/Principal | |
Ascenta Therapeutics, Inc.
Ascenta Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Ascenta Therapeutics, Inc. engages in the discovery and development of medicines for cancer. Its core technology consists of agents designed to re-establish the natural program of apoptosis (cell death) in abnormal cancer cells. Its has three small molecule programs against distinct apoptosis targets: Bcl-2 (AT-101 – an oral pan-Bcl2 inhibitor), IAP (AT-406 – an oral multi-IAP inhibitor) and HDM2. The company was founded by Dajun Yang, Marc E. Lippman, and Shaomeng Wang on June 5, 2006 and is headquartered in Malvern, PA. | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member Chief Executive Officer | |
Harvard Medical School | College/University | Corporate Officer/Principal Doctorate Degree Graduate Degree | |
Northeastern University
Northeastern University Other Consumer ServicesConsumer Services Founded in 1898, Northeastern University is a private research university located in the heart of Boston. Northeastern teaches worldwide experiential learning, urban engagement, and interdisciplinary research that meets global and societal needs. The University offers a range of undergraduate and graduate programs leading to degrees through the doctorate in nine colleges and schools. | College/University | Doctorate Degree Masters Business Admin Masters Business Admin | |
MOMENTA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director of Finance/CFO Chairman Director/Board Member | |
Context Therapeutics LLC
Context Therapeutics LLC Pharmaceuticals: MajorHealth Technology Context Therapeutics LLC develops novel medicines for hormone responsive cancers. The company was founded by Martin Lehr in 2016 and is headquartered in Philadelphia, PA. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member | |
The Wharton School of the University of Pennsylvania | College/University | Masters Business Admin Masters Business Admin Masters Business Admin | |
TREVI THERAPEUTICS, INC. | Biotechnology | Corporate Officer/Principal Director/Board Member Director/Board Member | |
OMEGA ALPHA SPAC | Financial Conglomerates | Founder Chief Executive Officer Founder | |
Senti Sub I, Inc.
Senti Sub I, Inc. BiotechnologyHealth Technology Senti Biosciences, Inc. develops novel therapeutics. It specializes in thetic biology, gene therapy and cell therapy. The company was founded by Timothy K. Lu, Wilson Wong, James J. Collins and Philip Lee in 2016 and is headquartered in South San Francisco, CA. | Biotechnology | Director/Board Member Founder Founder | |
SENTI BIOSCIENCES, INC. | Biotechnology | Director/Board Member Director/Board Member Founder | |
The Trustees of Columbia University in The City of New York | College/University | Graduate Degree Graduate Degree Graduate Degree | |
BioVascular, Inc.
BioVascular, Inc. Pharmaceuticals: MajorHealth Technology BioVascular, Inc. develops drugs and devices for control of intimal hyperplasia associated with vascular procedures. It is a integrated specialty cardiovascular therapeutic company, and to utilize corporate partnerships in markets that have complex marketing barriers and/or combination technologies. The company was founded by John H. Parrish and Paul F. Glidden in 2005 and is headquartered in San Diego, CA. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
The American Society for Clinical Pharmacology & Therapeutics
The American Society for Clinical Pharmacology & Therapeutics Miscellaneous Commercial ServicesCommercial Services The American Society for Clinical Pharmacology & Therapeutics is a scientific and professional organization that serves the disciplines of clinical pharmacology and translational medicine. The non-profit company is based in Alexandria, VA. The CEO of the company is Sharon Swan. | Miscellaneous Commercial Services | President Corporate Officer/Principal | |
MERCK & CO., INC. | Pharmaceuticals: Major | General Counsel Corporate Officer/Principal | |
DYNAVAX TECHNOLOGIES CORPORATION | Biotechnology | Director/Board Member Director of Finance/CFO | |
GILEAD SCIENCES, INC. | Biotechnology | Corporate Officer/Principal Corporate Officer/Principal | |
The University of California, San Francisco | College/University | Masters Business Admin Corporate Officer/Principal | |
Corvium, Inc.
Corvium, Inc. Packaged SoftwareTechnology Services Corvium, Inc. engages in the development of fist synthetic biology-based bacterial monitoring platform. Its product include Control-Pro, an EMP automation software that converts data into action. The company was founded by Bob Langer, Timothy Lu, Michael Koeris, Brett Chevalier, Micah Rosenbloom, Tanguy Chau, and James J. Collins in March 2009 and is headquartered in Woburnc, MA. | Packaged Software | Founder Founder | |
The Ohio State University
The Ohio State University Other Consumer ServicesConsumer Services Global Factory, Inc. provides collaborative manufacturing execution systems. The firm's software gather, organize & analyze demand, production & quality data from various sources and monitor key indicators & execute business processes to control, manage & optimize distributed manufacturing operations. The company was founded in 1999 and is headquartered in Santa Clara, CA. | College/University | Corporate Officer/Principal Doctorate Degree | |
Amunix Pharmaceuticals, Inc.
Amunix Pharmaceuticals, Inc. BiotechnologyHealth Technology Amunix Pharmaceuticals, Inc. manufactures and fabricates drugs. The firm’s pipeline products are based on proprietary XTEN half-life extension, Antibody-XTEN-Drug Conjugate, ProTIA pro-drug and bispecific T-cell engager platform technologies. The company was founded by Willem P.C. Stemmer and Volker Schellenberger in 2006 and is headquartered in Mountain View, CA. | Biotechnology | Director/Board Member Director/Board Member | |
Kellogg School of Management | College/University | Masters Business Admin Masters Business Admin | |
University of Delaware | College/University | Undergraduate Degree Undergraduate Degree | |
University of California, Irvine | College/University | Corporate Officer/Principal Undergraduate Degree | |
Domain Associates LLC
Domain Associates LLC Investment ManagersFinance Domain Associates LLC (Domain Associates) is a venture capital firm founded in 1985. The firm is headquartered in Princeton, New Jersey. | Investment Managers | Private Equity Investor Consultant / Advisor | |
Alliance for Regenerative Medicine
Alliance for Regenerative Medicine Medical/Nursing ServicesHealth Services ARM is a Washington, DC-based multi-stakeholder advocacy organization that promotes global initiatives necessary to facilitate access to life-giving advances in regenerative medicine. The organization promotes legislative, regulatory reimbursement, investment, technical, and other initiatives to accelerate the development of safe and effective regenerative medicine technologies. ARM also works to increase public understand- ing of the field and its potential to transform human healthcare. Prior to the formation of ARM in 2009, there was a need for more coordinated and cohesive advocacy representing the interests of the companies, research institutions, investors and patient groups that comprise the entire regenerative medicine community. Today ARM has more than 140 members and is the leading global advocacy organization in this field. | Medical/Nursing Services | Director/Board Member Director/Board Member |
Statistics
International
United States | 49 |
Cayman Islands | 2 |
United Kingdom | 2 |
Sectoral
Health Technology | 26 |
Consumer Services | 19 |
Finance | 4 |
Commercial Services | 3 |
Technology Services | 2 |
Operational
Director/Board Member | 604 |
Corporate Officer/Principal | 258 |
Independent Dir/Board Member | 186 |
Chairman | 120 |
Chief Executive Officer | 111 |
Most connected contacts
Insiders | |
---|---|
Nina Kjellson | 49 |
Ed Mathers Mathers | 47 |
Eckard Weber | 46 |
Brian H. Dovey | 40 |
Chau Khuong | 38 |
Peter Barrett | 38 |
John Maraganore | 38 |
Otello Stampacchia | 37 |
David Kabakoff | 30 |
Jeff Bird | 30 |
Maha Katabi | 28 |
Louis C. Bock | 27 |
G. Kirk Raab | 26 |
James Collins | 25 |
Jose-Carlos Gutiérrez-Ramos | 24 |
- Stock Market
- Insiders
- Michael Powell
- Company connections